Showing 1511-1520 of 2813 results for "".
- The Rise of Biostimulators: Complement, Not Competitor, in Aesthetic Regimenshttps://modernaesthetics.com/news/the-rise-of-biostimulators-complement-not-competitor-in-aesthetic-regimens/2485824/The filler category of medical aesthetics may have faced certain headwinds in 2025, but biostimulatory agents experienced a noticeable uptick. Still, at the 2026 Octane Aesthetics Tech Forum, “Flipping the Filler Script” panelists cautioned against viewing them as a replacement for hyaluronic aci
- CO2 Laser Plus CBT Shows Benefit in Postadolescent Acne Excoriée Case Serieshttps://modernaesthetics.com/news/co2-laser-plus-cbt-shows-benefit-in-postadolescent-acne-excoriee-case-series/2485795/A combined psychodermatologic approach integrating CO₂ laser ablation and cognitive-behavioral therapy (CBT) was associated with clinical improvement in patients with treatment-resistant postadolescent acne excoriée, according to a case series published in the February 2026 issue of Journal o
- Lynch Regenerative Medicine Names General Counsel, CMOhttps://modernaesthetics.com/news/lynch-regenerative-medicine-names-general-counsel-cmo/2485740/Lynch Regenerative Medicine (LRM), a regenerative medicine company focused on platelet-derived growth factor–based therapies, has named Madison Dini as General Counsel and Chad Lindemann as Chief Marketing Officer. According to the company, Dini will lead legal, compliance, and corporate g
- Systematic Review Supports Efficacy of Targeted HA Chin Injection Strategyhttps://modernaesthetics.com/news/systematic-review-supports-efficacy-of-targeted-ha-chin-injection-strategy/2485670/Chin augmentation with hyaluronic acid (HA) fillers has become a cornerstone of lower facial contouring. In a systematic review and meta-analysis published online in Aesthetic Plastic Surgery, the authors evaluated the safety and efficacy of a two-three-point injection technique for chin
- Merz Aesthetics Marks 15 Years of XEOMIN® With New National Campaignhttps://modernaesthetics.com/news/merz-aesthetics-marks-15-years-of-xeomin-with-new-national-campaign/2485650/Merz Aesthetics is commemorating 15 years since the US Food and Drug Administration (FDA) approved XEOMIN® (incobotulinumtoxinA) for aesthetic use, marking a milestone for the company’s flagship neurotoxin in the competitive US injectable market. Approved f
- Can Injectables and Facelifts Coexist? Early Data Suggest Yeshttps://modernaesthetics.com/news/can-injectables-and-facelifts-coexist-early-data-suggest-yes/2485646/Facelift surgery remains a foundational procedure for facial rejuvenation, but it may not fully correct age-related volume loss, skin quality changes, or dynamic rhytides. As a result, injectables and energy-based devices are frequently incorporated before and after rhytidectomy, despite limited
- A Whole-Face, Whole-Patient Framework Review for Aesthetic Consultationhttps://modernaesthetics.com/news/a-whole-face-whole-patient-framework-review-for-aesthetic-consultation/2485626/Aesthetic facial rejuvenation is increasingly defined by comprehensive, patient-centered assessment rather than isolated correction of individual features, according to a multidisciplinary review published in Dermatologic Surgery. Drawing on insights from dermatology, plastic surgery, an
- Aesthetic Sequelae of GLP-1 Receptor Agonists Highlighted in Clinical Reviewhttps://modernaesthetics.com/news/aesthetic-sequelae-of-glp-1-receptor-agonists-highlighted-in-clinical-review/2485615/Dermatologists are increasingly encountering aesthetic complications associated with GLP-1 receptor agonist (RA)–induced weight loss, according to a clinical review presented at the South Beach Symposium. The poster, b
- Prolactin Receptor Blockade May Promote Hair Growth via Follicular Stem Cell Activationhttps://modernaesthetics.com/news/prolactin-receptor-blockade-may-promote-hair-growth-via-follicular-stem-cell-activation/2485612/Blocking prolactin receptor (PRLR) signaling with the investigational antibody ABS-201 promoted hair follicle growth and stem cell activation in human male scalp skin models, according to preclinical data from Jérémy Chéret, PhD, MSc, at the South Beach Symposium
- Micro-Autologous Fat Transplantation Shows Durable Correction for Gummy Smile in Long-Term Studyhttps://modernaesthetics.com/news/micro-autologous-fat-transplantation-shows-durable-correction-for-gummy-smile-in-long-term-study/2485602/Micro-autologous fat transplantation (MAFT) may offer a durable, minimally invasive option for correcting gummy smile, according to a long-term retrospective study published online ahead of print in Plastic and Reconstructive Surgery. Investigators analyzed outcomes in 52 patients